Peet M, Middlemiss D N, Yates R A
Br J Psychiatry. 1981 Aug;139:112-7. doi: 10.1192/bjp.139.2.112.
Ten hospitalized chronic schizophrenic patients were given chlorpromazine alone and chlorpromazine plus high dose propranolol in two 7-week treatment periods according to a randomized crossover design. In the six patients who completed the whole study, plasma levels of chlorpromazine and chlorpromazine sulphoxide, total serum levels of neuroleptic and serum levels of prolactin were consistently and significantly elevated during treatment with chlorpromazine plus propranolol relative to levels during treatment with chlorpromazine alone. These effects are sufficient to explain previously reported clinical improvement in schizophrenic patients given propranolol in addition to neuroleptics.
十名住院的慢性精神分裂症患者,按照随机交叉设计,在两个为期7周的治疗阶段分别单独服用氯丙嗪以及氯丙嗪加高剂量普萘洛尔。在完成整个研究的六名患者中,与单独使用氯丙嗪治疗期间的水平相比,在氯丙嗪加普萘洛尔治疗期间,氯丙嗪和氯丙嗪亚砜的血浆水平、抗精神病药物的总血清水平以及催乳素的血清水平持续且显著升高。这些效应足以解释先前报道的在精神分裂症患者中除使用抗精神病药物外还给予普萘洛尔时出现的临床改善情况。